I wonder if Sanofi might lob an offer at SPL for this (if they aren't already involved)? If they are going to lose their Jevtana market share to SPL, given the spending spree Sanofi is on at the moment, it could get interesting.
- Forums
- ASX - By Stock
- SPL
- Ann: Starpharma to commence DEP cabazitaxel phase 1/2 trial
Ann: Starpharma to commence DEP cabazitaxel phase 1/2 trial, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.5¢ | $35.24K | 364.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 18326 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 15262 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 18326 | 0.095 |
3 | 160000 | 0.094 |
3 | 134307 | 0.092 |
3 | 81442 | 0.090 |
1 | 30000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 15262 | 2 |
0.100 | 38876 | 3 |
0.105 | 199768 | 2 |
0.110 | 168286 | 9 |
0.115 | 85453 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |